Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer
Background. ZNF385B, a zinc finger protein, has been known as a potential biomarker in some neurological and hematological studies recently. Although numerous studies have demonstrated the potential function of zinc finger proteins in tumor progression, the effects of ZNF385B in breast cancer (BC) a...
Main Authors: | Ning Yan, Cong Liu, Fang Tian, Ling Wang, Yimin Wang, Zhaoying Yang, Yan Jiao, Miao He |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2021/4301802 |
Similar Items
-
Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer
by: Julie A. Vendrell, et al.
Published: (2019-01-01) -
ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival.
by: Bente Vilming Elgaaen, et al.
Published: (2012-01-01) -
Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification
by: Zhao Liu, et al.
Published: (2021-04-01) -
Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
by: Yan Jiao, et al.
Published: (2019-01-01) -
Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma
by: Wenxia Meng, et al.
Published: (2019-01-01)